By rray, 2 August, 2024 Main benefit of screening is detecting CA at earlier stage when it may be easier to treat Risks cons to screening include 9
By rray, 2 August, 2024 Follow same guidance in transgender women regardless of hormone tx or gender affirming surgery 14 15 if digital exam indicated neovaginal approach may be more effective than rectal 15
By rray, 2 August, 2024 If very suspicious DRE and or PSA 3 ng mL bx indicated 3 Validated risk calculators may be used to inform shared decision making process for prostate bx CR AUA B 13
By rray, 2 August, 2024 Per NCCN if normal DRE and high risk w PSA 3 or average risk w PSA 1 3 ng mL retest q1 2y 3
By rray, 2 August, 2024 Per ACP no evidence that screening more often than q4y offers additional benefit 12
By rray, 2 August, 2024 Rescreen interval or d c of screening based on pt preference age PSA prostate CA risk life expectancy and general health following shared decision making CR AUA B 13